Journal of Receptors and Signal TransductionPharmacology & ToxicologyPeer-reviewed journal article
Curcumin Analogues as the Inhibitors of TLR4 Pathway in Inflammation and Their Drug Like Potentialities: A Computer-based Study
Abstract
In this study Curcumin and their different analogues have been analyzed as the inhibitors of signaling proteins i.e., Cycloxygenase-2 (COX-2), Inhibitor of Kappa{beta} Kinase (IKK) and TANK binding kinase-1 (TBK-1) of Toll Like Receptor 4 (TLR4) pathway involved in inflammation using computational tools. Multiple analogues showed better binding affinity than the approved drugs for the respective targets. Upon continuous computational exploration 6-Gingerol, Yakuchinone A and Yakuchinone B were identified as the best inhibitors of COX-2, IKK and TBK-1 respectively. Then their drug like potentialities were analyzed in different experiments where they also performed sound and similar. Hopefully, this study will uphold the efforts of researchers to identify anti-inflammatory drugs from natural sources.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Quercetin And Quercetin Derivatives Interaction With Cyclooxygenase-1 And Cyclooxygenase-2
A.E. Manukyan, Ashkhen A. Hovhannisyan·bioRxiv·Dec 5, 2020
- Study of In silico Anti-Inflammatory Potential of Tyramine-Fe complex in Brotowali Plants
T.W. Wimbuh, B.S. Sutiman, … H. S Djoko·bioRxiv·Aug 24, 2020
- Podophyllotoxin And Quercetin In Silico Derivatives Docking Analysis With Cyclooxygenase-2 And Aminopeptidase-N
A.E. Manukyan, Ashkhen A. Hovhannisyan·bioRxiv·Feb 26, 2021
- Further Exploration of the SAR of Imidazoquinolines; Identification of Potent C7 Substituted Imidazoquinolines
J. Hunt, P. A. Kleindl, … M. L. Forrest·bioRxiv·Oct 4, 2019
- Molecular Docking Studies of Phytochemicals of Allophylus serratus Against Cyclooxygenase-2 Enzyme
K. Jemal·bioRxiv·Dec 5, 2019
- Potent and Selective IL-4 Inhibitors with Anti-Tumor Activity
Raavi, Imron Chaudhry, … Arturo J. Vegas·bioRxiv·Feb 4, 2026